168
Participants
Start Date
March 1, 2015
Primary Completion Date
March 1, 2016
Study Completion Date
February 1, 2017
Antiviral drugs
sofosbuvir, ribavirin, daclatasvir, ledipasvir, simeprevir, paritaprevir, dasabuvir, ombitasvir
University of Cagliari
OTHER
University of Turin, Italy
OTHER
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello
OTHER
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
OTHER
Ente Ospedaliero Ospedali Galliera
OTHER
University of Campania Luigi Vanvitelli
OTHER
Cardarelli Hospital
OTHER
Reggio Calabria
OTHER
University of Palermo
OTHER
Società Italiana Talassemie ed Emoglobinopatie
OTHER